Medical imaging artificial intelligence (AI) company Avicenna.AI announced it has received CE Mark clearance for its Cina Aspects AI tool for assessing the severity of a stroke from brain CT scans.
Cina Aspects automatically processes noncontrast CT scans to assist radiologists within their existing systems and workflow. The tool uses a topographic scoring system to quantify the severity of a stroke from a CT scan of the brain.
The software divides the brain territory affected by a stroke into 10 areas of interest and provides a score between 0 and 10, where 10 is normal and 0 indicates widespread ischemic damage throughout the affected area, according to a press release.
Avicenna received 510(k) clearance from the U.S. Food and Drug Administration last year for Cina Head, an AI solution for neurovascular emergencies.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
